Malignant otitis externa is a serious, potentially life-threatening infection that starts in the ear canal and spreads into the surrounding bone. Despite its name, it is not cancer. The term “malignant” reflects how aggressively the infection behaves, eating through bone and soft tissue if left untreated. It overwhelmingly affects older adults with diabetes, with an estimated 90 to 100% of patients having diabetes as an underlying condition.
How It Differs From Regular Swimmer’s Ear
Ordinary otitis externa, commonly called swimmer’s ear, is a superficial infection of the ear canal skin. It causes itching, redness, and mild pain, and it clears up with eardrops in most cases. Malignant otitis externa starts in a similar way but refuses to stay contained. The infection penetrates through the floor of the ear canal into the temporal bone, the thick bone that houses the ear structures. From there, it can spread to the base of the skull, reaching the marrow of the temporal, sphenoid, and occipital bones.
This bone infection, called osteomyelitis, is what makes the condition dangerous. The infection can erode through bone to reach the structures of the inner ear, the joint of the jaw, and eventually the spaces around the brain. In people with diabetes, poor blood circulation in the small vessels of the ear canal creates an environment where bacteria thrive and the immune system struggles to respond.
Who Gets It
The typical patient is over 65, has diabetes, and often has additional health problems. Diabetes is by far the dominant risk factor, present in the vast majority of cases. The combination of high blood sugar (which feeds bacteria), damaged small blood vessels (which limits the body’s healing response), and age-related immune decline creates near-perfect conditions for the infection to take hold.
People who are immunocompromised for other reasons are also at risk. This includes people living with HIV, those undergoing chemotherapy, organ transplant recipients on immune-suppressing medications, and people with blood disorders like leukemia. Malnutrition is another recognized risk factor.
What Causes the Infection
The bacterium Pseudomonas aeruginosa is responsible for roughly half of all cases. It is a hardy, opportunistic organism that thrives in warm, moist environments like the ear canal. But the list of possible culprits has been growing. MRSA, a drug-resistant staph bacterium, is appearing more often. Other bacteria like Klebsiella, Proteus, and E. coli have also been identified. In about 17% of cases in one study, fungi were responsible, most commonly Candida species and Aspergillus. Knowing the exact organism matters because it determines which medications will work.
Symptoms to Recognize
The hallmark symptom is severe, deep ear pain that is noticeably worse at night. This pain is out of proportion to what the ear looks like on examination, and it does not respond to the usual eardrops prescribed for swimmer’s ear. Persistent drainage from the ear is common, often foul-smelling. Hearing loss can develop as the infection involves the middle and inner ear structures.
When the infection spreads deeper, it can damage the cranial nerves that pass through the base of the skull. About 43% of patients in one study had cranial nerve involvement. The facial nerve is the most commonly affected, causing weakness or paralysis on one side of the face. This is a red flag that the infection has progressed significantly. The lower cranial nerves can also be involved, leading to difficulty swallowing, hoarseness, or weakness in the tongue and shoulder. Notably, lower cranial nerve problems tend to recover fully with treatment, while facial nerve paralysis is significantly less likely to improve.
How It Is Diagnosed
Diagnosis relies on a combination of clinical suspicion, lab work, and imaging. When an ear infection in an elderly diabetic patient fails to improve with standard treatment, malignant otitis externa should be on the radar.
Blood tests measuring inflammation are useful both for diagnosis and for tracking whether treatment is working. The erythrocyte sedimentation rate (ESR), a general marker of inflammation, is typically elevated. In one study, the average ESR at diagnosis was about 53 mm/h and dropped to around 15 mm/h by the time patients were discharged. Patients whose infections did not respond to treatment had much higher inflammatory markers at the outset, with average ESR levels near 96 mm/h compared to about 35 mm/h in those who responded well.
CT scans are preferred for the initial workup because they excel at revealing bone erosion and the early signs of damage to the ear canal and skull base. MRI is better at showing soft tissue involvement and is the method of choice for detecting whether the infection has spread inside the skull, caused blood clots in nearby veins, or reached the lining of the brain. Most patients need both types of imaging at different points in their care.
Treatment and What to Expect
Treatment centers on long-term intravenous antibiotics and strict blood sugar control. Because Pseudomonas is the most common cause, initial antibiotic therapy typically targets this organism. However, cultures from the ear are essential because the growing diversity of causative organisms, including fungi and drug-resistant bacteria, means a one-size-fits-all approach can fail.
Treatment courses are long, often lasting six weeks or more. The duration is guided by symptoms, repeat imaging, and declining inflammatory markers in the blood. Tight diabetes management is not optional during treatment; it is considered essential for any antibiotic regimen to succeed.
Most patients respond to antibiotics alone. Surgery is reserved for cases classified as refractory, meaning the infection has not improved after at least six weeks of appropriate antibiotic therapy. In these situations, the goal of surgery is to remove dead and infected bone tissue, drain any abscesses, and create pathways for ongoing drainage. There is a growing consensus that early surgical intervention may be warranted in severe refractory cases, given the high stakes of allowing the infection to progress unchecked.
Prognosis and Complications
Outcomes have improved dramatically since the condition was first described, when mortality rates exceeded 50%. With modern antibiotics and imaging, the in-hospital mortality rate is around 2.5%. However, longer-term follow-up studies report mortality rates between 3.6% and 14%, reflecting the fact that the infection can recur and that the patient population is elderly with multiple health problems.
Age is a significant factor. Mortality ranges from essentially 0% in patients under 30 to 4.3% in those 85 and older. Sepsis is the most dangerous complication, diagnosed in about 11% of hospitalized patients and associated with an 18-fold increase in the risk of death. Other conditions that worsen the outlook include heart failure, significant weight loss, and blood clotting disorders.
Recurrence is a real concern. Even after successful treatment, the underlying conditions that made the infection possible, primarily diabetes and immune compromise, remain. Patients who have had malignant otitis externa need ongoing attention to any new ear symptoms, because catching a recurrence early makes a significant difference in outcomes.